Dangerous Reaction Mixing Household Products - Chemical Reaction Warning

This is why you should never mix chemicals or products if you do not know the possible reactions that can occur. Products that have such dangerous reactions should not be stored together. This reaction involves the use of potassium permanganate.

Spotlight

Morphotek, Inc.

Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mABs) to treat these diseases and continues to develop additional antibody products using its proprietary technologies.

OTHER VIDEOS

Controlling exothermic reactions with AVA Lab Control Software

video | March 30, 2023

AVA Lab Control Software allows you to automate your chemistry by remotely controlling the devices connected to your jacketed lab reactor with full process data logging....

Watch Now

Processing For Modelling Hydrogen Atoms In Protein Structures

video | March 22, 2023

Neutron Crystallography Data Collection and Processing for Modelling Hydrogen Atoms in Protein Structures....

Watch Now

Phosphoproteomic Strategy for Profiling Osmotic Stress Signaling

video | March 17, 2023

Presented here is a phosphoproteomic approach, namely stop and go extraction tip based phosphoproteomic, which provides high-throughput and deep coverage of Arabidopsis phosphoproteome. This approach delineates the overview of osmotic stress signaling in Arabidopsis....

Watch Now

In-cell Fast Photochemical Oxidation of Proteins

video | March 14, 2023

Characterizing Cellular Proteins with In-cell Fast Photochemical Oxidation of Proteins - a 2 minute Preview of the Experimental Protocol...

Watch Now

Spotlight

Morphotek, Inc.

Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mABs) to treat these diseases and continues to develop additional antibody products using its proprietary technologies.

Events